Cases & Deals

AquaBounty completes $10 million sale of Common Shares to Intrexon

Clients AquaBounty Technologies

Jones Day represented AquaBounty Technologies, a biotechnology company focused on enhancing productivity in the aquaculture market, in its $10 million sale of new Common Shares to Intrexon Corporation, a biotechnology company operating in the synthetic biology field.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.